Vaccine-based clinical protection against SARS-CoV-2 infection and the humoral immune response: A 1-year follow-up study of patients with multiple sclerosis receiving ocrelizumab

por Räuber, Saskia, Willison, Alice, Korsen, Melanie, Kölsche, Tristan, Golombeck, Kristin S., Plaack, Benedikt, Schüller, Julia, Huntemann, Niklas, Rolfes, Leoni, Schroeter, Christina B., Nelke, Christopher, Regner-Nelke, Liesa, Förster, Moritz, Ringelstein, Marius, Barnett, Michael Harry, Hartung, Hans-Peter, Aktas, Orhan, Albrecht, Philipp, Ruck, Tobias, Melzer, Nico, Meuth, Sven G., Kremer, David
Publicado 2022